Your browser doesn't support javascript.
loading
Instruments Measuring Physical Function for Psoriatic Arthritis Endorsed at GRAPPA 2020 Annual Meeting: Updates of the GRAPPA-OMERACT Working Group.
Leung, Ying Ying; Orbai, Ana-Maria; Tillett, William; Ogdie, Alexis; Eder, Lihi; Goel, Niti; Hojgaard, Pil; Holland, Richard; Mathew, Ashish J; Lindsay, Christine A; Antony, Anna; Chau, Jeffrey; Christensen, Robin; Coates, Laura C; Mease, Philip J; Strand, Vibeke; FitzGerald, Oliver; de Wit, Maarten; Callis Duffin, Kristina; Gladman, Dafna D.
Afiliação
  • Leung YY; As part of the supplement series GRAPPA 2020, this report was reviewed internally and approved by the Guest Editors for integrity, accuracy, and consistency with scientific and ethical standards. The authors are members of the Outcome Measures in Rheumatology (OMERACT), an organization that develops
  • Orbai AM; As part of the supplement series GRAPPA 2020, this report was reviewed internally and approved by the Guest Editors for integrity, accuracy, and consistency with scientific and ethical standards. The authors are members of the Outcome Measures in Rheumatology (OMERACT), an organization that develops
  • Tillett W; As part of the supplement series GRAPPA 2020, this report was reviewed internally and approved by the Guest Editors for integrity, accuracy, and consistency with scientific and ethical standards. The authors are members of the Outcome Measures in Rheumatology (OMERACT), an organization that develops
  • Ogdie A; As part of the supplement series GRAPPA 2020, this report was reviewed internally and approved by the Guest Editors for integrity, accuracy, and consistency with scientific and ethical standards. The authors are members of the Outcome Measures in Rheumatology (OMERACT), an organization that develops
  • Eder L; As part of the supplement series GRAPPA 2020, this report was reviewed internally and approved by the Guest Editors for integrity, accuracy, and consistency with scientific and ethical standards. The authors are members of the Outcome Measures in Rheumatology (OMERACT), an organization that develops
  • Goel N; As part of the supplement series GRAPPA 2020, this report was reviewed internally and approved by the Guest Editors for integrity, accuracy, and consistency with scientific and ethical standards. The authors are members of the Outcome Measures in Rheumatology (OMERACT), an organization that develops
  • Hojgaard P; As part of the supplement series GRAPPA 2020, this report was reviewed internally and approved by the Guest Editors for integrity, accuracy, and consistency with scientific and ethical standards. The authors are members of the Outcome Measures in Rheumatology (OMERACT), an organization that develops
  • Holland R; As part of the supplement series GRAPPA 2020, this report was reviewed internally and approved by the Guest Editors for integrity, accuracy, and consistency with scientific and ethical standards. The authors are members of the Outcome Measures in Rheumatology (OMERACT), an organization that develops
  • Mathew AJ; As part of the supplement series GRAPPA 2020, this report was reviewed internally and approved by the Guest Editors for integrity, accuracy, and consistency with scientific and ethical standards. The authors are members of the Outcome Measures in Rheumatology (OMERACT), an organization that develops
  • Lindsay CA; As part of the supplement series GRAPPA 2020, this report was reviewed internally and approved by the Guest Editors for integrity, accuracy, and consistency with scientific and ethical standards. The authors are members of the Outcome Measures in Rheumatology (OMERACT), an organization that develops
  • Antony A; As part of the supplement series GRAPPA 2020, this report was reviewed internally and approved by the Guest Editors for integrity, accuracy, and consistency with scientific and ethical standards. The authors are members of the Outcome Measures in Rheumatology (OMERACT), an organization that develops
  • Chau J; As part of the supplement series GRAPPA 2020, this report was reviewed internally and approved by the Guest Editors for integrity, accuracy, and consistency with scientific and ethical standards. The authors are members of the Outcome Measures in Rheumatology (OMERACT), an organization that develops
  • Christensen R; As part of the supplement series GRAPPA 2020, this report was reviewed internally and approved by the Guest Editors for integrity, accuracy, and consistency with scientific and ethical standards. The authors are members of the Outcome Measures in Rheumatology (OMERACT), an organization that develops
  • Coates LC; As part of the supplement series GRAPPA 2020, this report was reviewed internally and approved by the Guest Editors for integrity, accuracy, and consistency with scientific and ethical standards. The authors are members of the Outcome Measures in Rheumatology (OMERACT), an organization that develops
  • Mease PJ; As part of the supplement series GRAPPA 2020, this report was reviewed internally and approved by the Guest Editors for integrity, accuracy, and consistency with scientific and ethical standards. The authors are members of the Outcome Measures in Rheumatology (OMERACT), an organization that develops
  • Strand V; As part of the supplement series GRAPPA 2020, this report was reviewed internally and approved by the Guest Editors for integrity, accuracy, and consistency with scientific and ethical standards. The authors are members of the Outcome Measures in Rheumatology (OMERACT), an organization that develops
  • FitzGerald O; As part of the supplement series GRAPPA 2020, this report was reviewed internally and approved by the Guest Editors for integrity, accuracy, and consistency with scientific and ethical standards. The authors are members of the Outcome Measures in Rheumatology (OMERACT), an organization that develops
  • de Wit M; As part of the supplement series GRAPPA 2020, this report was reviewed internally and approved by the Guest Editors for integrity, accuracy, and consistency with scientific and ethical standards. The authors are members of the Outcome Measures in Rheumatology (OMERACT), an organization that develops
  • Callis Duffin K; As part of the supplement series GRAPPA 2020, this report was reviewed internally and approved by the Guest Editors for integrity, accuracy, and consistency with scientific and ethical standards. The authors are members of the Outcome Measures in Rheumatology (OMERACT), an organization that develops
  • Gladman DD; As part of the supplement series GRAPPA 2020, this report was reviewed internally and approved by the Guest Editors for integrity, accuracy, and consistency with scientific and ethical standards. The authors are members of the Outcome Measures in Rheumatology (OMERACT), an organization that develops
J Rheumatol ; 2021 Mar 01.
Article em En | MEDLINE | ID: mdl-33649070
ABSTRACT
The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)-Outcome Measures in Rheumatology (OMERACT) Psoriatic Arthritis (PsA) Working Group provided updates at the 2020 GRAPPA annual meeting on its work toward developing a core outcome set for PsA. Working groups were set up for the 4 prioritized domains enthesitis, fatigue, structural damage, and physical function. Two instruments for measurement of physical function were provisionally endorsed (1) the Health Assessment Questionnaire-Disability Index and (2) the physical functioning domain in the Medical Outcomes Study 36-item Short Form survey.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article